翔宇医疗
(688626)
| 流通市值：61.62亿 | | | 总市值：61.62亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 186,048,007.84 | 743,531,309.94 | 506,631,855.69 | 337,859,279.17 |
| 营业收入 | 186,048,007.84 | 743,531,309.94 | 506,631,855.69 | 337,859,279.17 |
| 二、营业总成本 | 174,616,462.57 | 656,507,923.06 | 445,424,113.28 | 285,343,029.29 |
| 营业成本 | 64,551,957.53 | 242,252,961.72 | 167,916,823.19 | 107,375,921.06 |
| 税金及附加 | 2,967,585.7 | 10,732,522.6 | 7,450,851.56 | 5,018,819.44 |
| 销售费用 | 52,783,769.61 | 214,984,766.15 | 143,866,775.48 | 94,579,113.57 |
| 管理费用 | 13,931,440 | 60,230,189.31 | 38,414,969.86 | 23,972,826.81 |
| 研发费用 | 38,245,456.2 | 152,022,069.57 | 104,122,259.04 | 65,668,279.41 |
| 财务费用 | 2,136,253.53 | -23,714,586.29 | -16,347,565.85 | -11,271,931 |
| 其中:利息费用 | 4,513,244.87 | 3,627,760.53 | 2,584,140.55 | 1,812,293.85 |
| 其中:利息收入 | 4,929,009.98 | 25,199,060.6 | 18,070,974.2 | 11,928,505.38 |
| 加:投资收益 | 422,125.61 | 1,400,899.49 | 1,393,619.01 | 1,337,909.86 |
| 资产处置收益 | 137.98 | 66,478.93 | 12,898.25 | 12,898.25 |
| 资产减值损失(新) | -1,423,979.97 | -9,188,838.54 | -3,665,081.45 | -3,056,971.77 |
| 信用减值损失(新) | -261,954.96 | -4,199,656.13 | -2,266,868.32 | -1,244,591.04 |
| 其他收益 | 15,774,264.88 | 33,411,168.61 | 23,245,503.7 | 11,764,138.31 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 25,942,138.81 | 108,513,439.24 | 79,927,813.6 | 61,329,633.49 |
| 加:营业外收入 | 25,074.05 | 72,481.17 | 121,783.53 | 59,775.89 |
| 减:营业外支出 | 776,795.54 | 1,350,731.23 | 845,210.87 | 271,387.22 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 25,190,417.32 | 107,235,189.18 | 79,204,386.26 | 61,118,022.16 |
| 减:所得税费用 | 2,818,295.62 | 4,382,093.12 | 5,822,090.36 | 4,527,243.87 |
| 六、净利润 | 22,372,121.7 | 102,853,096.06 | 73,382,295.9 | 56,590,778.29 |
| 持续经营净利润 | 22,372,121.7 | 102,853,096.06 | 73,382,295.9 | 56,590,778.29 |
| 归属于母公司股东的净利润 | 22,951,013.6 | 102,943,557.79 | 73,413,939.05 | 56,635,866.17 |
| 少数股东损益 | -578,891.9 | -90,461.73 | -31,643.15 | -45,087.88 |
| (一)基本每股收益 | 0.15 | 0.66 | 0.47 | 0.36 |
| (二)稀释每股收益 | 0.15 | 0.69 | 0.51 | 0.4 |
| 九、综合收益总额 | 22,372,121.7 | 102,853,096.06 | 73,382,295.9 | 56,590,778.29 |
| 归属于母公司股东的综合收益总额 | 22,951,013.6 | 102,943,557.79 | 73,413,939.05 | 56,635,866.17 |
| 归属于少数股东的综合收益总额 | -578,891.9 | -90,461.73 | -31,643.15 | -45,087.88 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |